Roth MKM lowered the firm’s price target on Rocket Lab (RKLB) to $25 from $30 and keeps a Buy rating on the shares. The company reported Q4 revenue ahead of consensus but guided Q1 below consensus, reflecting normalizing launch and space systems levels following a strong quarter, though investors will be encouraged by Rocket Lab affirming a Neutron launch timeframe in the second half of the year with significant progress being made to-date, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RKLB:
- Rocket Lab provides update on Pioneer spacecraft mission
- Rocket Lab price target lowered to $28 from $32 at KeyBanc
- Citi trims Rocket Lab target, sees ‘enhanced buying opportunity’
- Strong Buy Rating for Rocket Lab USA Amid Impressive Performance and Strategic Advancements
- Rocket Lab Reports Record Revenue and Growth in 2024